avapro has been researched along with Extramembranous Glomerulopathy in 1 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, Y | 1 |
| Ma, L | 1 |
| Wang, C | 1 |
| Kong, D | 1 |
| Wang, Y | 1 |
| Mei, C | 1 |
1 trial available for avapro and Extramembranous Glomerulopathy
| Article | Year |
|---|---|
Effectiveness of sulodexide might be associated with inhibition of complement system in hepatitis B virus-associated membranous nephropathy: An inspiration from a pilot trial.
Topics: Adult; Anticoagulants; Antihypertensive Agents; Antiviral Agents; Biphenyl Compounds; Complement Sys | 2016 |